Spinal cord compression after radiolabeled metaiodobenzylguanidine analogue therapy in advanced malignant insulinoma.

about

Treatment of symptomatic neuroendocrine tumor syndromes: recent advances and controversies.

P2860

Q38956091-21B94494-694D-45EC-A9B5-E599B3037E88

P2860

Spinal cord compression after radiolabeled metaiodobenzylguanidine analogue therapy in advanced malignant insulinoma.

Item

http://www.wikidata.org/entity/Q38494154

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Spinal cord compression after ...... advanced malignant insulinoma.

@en

type

Item

label

Spinal cord compression after ...... advanced malignant insulinoma.

@en

prefLabel

Spinal cord compression after ...... advanced malignant insulinoma.

@en

P1476

Spinal cord compression after ...... advanced malignant insulinoma.

@en

P2093

Adelina Sanches

http://www.w3.org/2001/XMLSchema#string

Alina Coutinho Rodrigues Feitosa

http://www.w3.org/2001/XMLSchema#string

Dálvaro Oliveira de Castro Júnior

http://www.w3.org/2001/XMLSchema#string

José Rocha Filho

http://www.w3.org/2001/XMLSchema#string

Marcony Queiroz Andrade

http://www.w3.org/2001/XMLSchema#string

Melba Moura

http://www.w3.org/2001/XMLSchema#string

P2860

Radiofrequency ablation of neuroendocrine liver metastases: the Middlesex experience.

Therapy of neuroendocrine tumors with radiolabeled MIBG and somatostatin analogues.

Everolimus for advanced pancreatic neuroendocrine tumors.

The value of radiolabelled MIBG and octreotide in the diagnosis and management of neuroendocrine tumours.

Hormonal crises following receptor radionuclide therapy with the radiolabeled somatostatin analogue [177Lu-DOTA0,Tyr3]octreotate.

Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: chemotherapy in patients with neuroendocrine tumors.

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: peptide receptor radionuclide therapy with radiolabeled somatostatin analogs.

Radioiodine therapy for hyperthyroidism.

Functioning insulinoma--incidence, recurrence, and long-term survival of patients: a 60-year study.

P304

186-189

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1590/2359-3997000000033

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276532391

http://www.w3.org/2001/XMLSchema#string

P698

25993683

http://www.w3.org/2001/XMLSchema#string

Spinal cord compression after radiolabeled metaiodobenzylguanidine analogue therapy in advanced malignant insulinoma.

about

P2860

P2860

Spinal cord compression after radiolabeled metaiodobenzylguanidine analogue therapy in advanced malignant insulinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698